H5N1 News and Research

Latest H5N1 News and Research

Australian bird flu scare spurs widespread poultry bans

After the bird flu outbreak at two Victorian duck farms, other countries like Japan, Vietnam, Singapore and Hong Kong have placed bans on all poultry products from Victoria and across Australia. South Africa is also now asking certification that an Australian poultry import has not come from within 20km of the quarantined sites.

2 Feb 2012

National Science Advisory Board explains decision to censor bird flu research

"Details of a genetically altered strain of the deadly avian flu virus are 'a grave concern' to public safety and should be kept under wraps," the 23-member National Science Advisory Board for Biosecurity declared Tuesday "in a letter released by the journals Science and Nature," CNN reports.

2 Feb 2012

Natural resistance to flu could hold key to universal vaccine

Researchers have found that on infecting 41 healthy volunteers with different strains of flu virus, those with higher levels of a specific type of white blood cell were less likely to develop severe illness. Now the team of researchers hopes to mimic the natural resistance shown by some of the volunteers, by creating a vaccine that boosts levels of a particular subset of the 'T-cells'.

1 Feb 2012

Bird flu virus research and need for censorship

A group of scientists have been working on a genetically modified strain of bird flu. A federal advisory board declared Tuesday that the details of the research are a “grave concern” to public safety and should be kept under wraps.

1 Feb 2012

ASM to publish special commentaries on NSABB and H5N1 research

In response to recent actions of the U.S. National Science Advisory Board for Biosecurity (NSABB), which recommended that two scientific journals withhold crucial details in upcoming reports about experiments with a novel strain of the bird flu virus, H5N1, the American Society for Microbiology (ASM) will publish a special series of commentaries by prominent scientists, including the acting chair of the NSABB, weighing in on whether the recommendations were necessary and what role biosecurity considerations should play in the dissemination of research findings.

1 Feb 2012

Media outlets continue to publish expert opinion regarding H5N1 bird flu research

The PBS NewsHour blog "The Rundown" features excerpts from interviews with three experts discussing the recent debate over research conducted on the H5N1 bird flu virus.

1 Feb 2012

NanoViricides files FluCide pre-IND briefing document with the FDA

NanoViricides, Inc. announced today that it has submitted a pre-IND briefing document to the US FDA. This submission provides the required information for the Company's highly effective anti-influenza drug candidate, FluCide, in support of a pre-IND Meeting.

1 Feb 2012

Experts to discuss controversial studies on avian flu virus at live event

On February 2 from 6pm to 8pm, the Emerging Infectious Diseases & Microbiology Discussion Group of the New York Academy of Sciences presents Dual Use Research: H5N1 Influenza Virus and Beyond, a discussion between scientists, publishers, and legal experts that will explore the myriad issues surrounding the impending publication of these two studies and measures that will need to be undertaken to ensure the security of future such research.

31 Jan 2012

Bird flu detected in Victoria spurs action

A bird flu outbreak has been detected at two Victorian farms and at least 10,000 ducks will have to be destroyed. The two farms are about 25km apart in an area north of Melbourne, but officials are keeping the exact location private.

30 Jan 2012

Bird flu investigator says continuation of research remains 'urgent' despite moratorium

Research into transmissible bird flu strains remains "urgent" despite flu investigators' recent declaration of a "60-day moratorium on avian flu transmission because of the current controversy," Yoshihiro Kawaoka of Tokyo University and the University of Wisconsin-Madison, "a lead researcher on one of two recent studies showing how H5N1 can be transmitted through airborne droplets" among ferrets, writes in a commentary published Wednesday in the journal Nature, Reuters reports.

27 Jan 2012

Voluntary action by two research teams to halt work on H5N1 lauded

A Georgetown University Medical Center professor says the voluntary action taken by two research teams to temporarily halt work involving the highly pathogenic avian influenza H5N1 is "laudable."

24 Jan 2012

Settling controversy surrounding bird flu research will not be easy

The WHO is expected to hold a meeting in February to discuss controversy over recent research on the H5N1 bird flu virus, after the U.S. National Scientific Advisory Board for Biosecurity (NSABB) in December advised the journals Science and Nature to withhold publishing two teams' research on the virus for fear the information could "fall into the wrong hands," a commentary in the Economist's "Babbage" blog states.

24 Jan 2012

Scientists halt bird flu research for 60 days amid safety concerns

The head of the NIH National Institute of Allergy and Infectious Diseases (NIAID), which funded "two projects that created a highly pathogenic [H5N1] flu virus mutation, has welcomed a two-month moratorium on further research while defending the value and safety of the experiments," the Financial Times reports.

24 Jan 2012

Debate over publication of bird flu studies continues in journal opinion pieces

Ron Fouchier of Erasmus Medical Center in the Netherlands -- lead researcher of one of two teams that last year reported study results "that showed how the H5N1 [bird flu] virus can be transmitted through airborne droplets between ferrets, a model for studying influenza in humans."

21 Jan 2012

Georgetown professors explore balance of national security and scientific freedom

The U.S. government's request that the journals Science and Nature withhold scientific information related to the genetically modified H5N1 virus because of biosecurity concerns does not violate the First Amendment, say two Georgetown University professors. They caution, however, that a fair, transparent process undertaken by research organizations is preferable to governmental constraints on disseminating scientific information.

19 Jan 2012

Risks of modifying flu strains to become highly transmissible in humans outweigh benefits

In this Journal Sentinel Online opinion piece, Thomas Inglesby, chief executive officer and director of the Center for Biosecurity of UPMC in Baltimore; Anita Cicero, chief operating officer and deputy director of the center; and D.A. Henderson, a distinguished scholar at the center, comment on a recent announcement by scientists that they have genetically modified a strain of H5N1 bird flu that is "capable of spreading through the air between ferrets that were physically separated from each other," indicating "it would be readily transmissible by air between humans."

19 Jan 2012

NIH official discusses reaction to bird flu studies, development of publishing mechanism in Nature interview

Nature interviews Amy Patterson, director of the National Institutes of Health (NIH) Office of Science Policy, which administers the National Science Advisory Board for Biosecurity (NSABB), about the board's decision in December to advise against full publication of "two papers on avian flu (H5N1) that could pose a biosecurity risk if published in their entirety."

13 Jan 2012

Restricting publication of H5N1 research 'more perilous' than threat of biological warfare

In this Reuters opinion piece, New York-based writer Peter Christian Hall responds to "the U.S. government's move to restrict publication of vital research into H5N1 avian flu," writing, "This unprecedented interference in the field of biology could hinder research and hamper responsiveness in distant lands plagued by H5N1," yet "no one seems to be challenging a key assumption -- that H5N1 could make a useful weapon. It wouldn't."

11 Jan 2012

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby Pharmaceutical Company (CPC) today announced publication of new results showing that a single dose of JVRS-100 adjuvanted H5N1 influenza vaccine enhanced-immune responses, -dose sparing, and -cross-clade influenza virus protection.

9 Jan 2012

WHO confirms bird flu cases in Egypt, China

The WHO on Thursday "announced the deaths of two men from H5N1 avian influenza, one from Egypt and another from China whose death was reported earlier in the media," CIDRAP News reports. Both men are suspected to have contracted the virus from avian sources, although an investigation into the man from China's exposure to the virus is ongoing, according to news service.

7 Jan 2012